COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
11. Oktober 2024 06:35 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott
23. Februar 2023 07:58 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
Global Anti-Asthmatics and COPD Drugs Market Report 2021 with Focus on COVID-19 Impacts - Major Players are Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca
21. Mai 2021 05:13 ET
|
Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...